Mouse models of human bladder cancer as a tool for drug discovery

Catherine Seager*, Anna M. Puzio-Kuter, Carlos Cordon-Cardo, James McKiernan, Cory Abate-Shen

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations

Abstract

Muscle-invasive bladder cancer is a deadly condition in dire need of effective new treatments. This unit contains a description of mouse models suitable for the evaluation of potential new therapies. Included is a genetically engineered mouse model of bladder cancer generated by the delivery of an adenovirus expressing Cre recombinase into the bladder lumen. Also described is an orthotopic mouse model created by the instillation of human bladder tumor cells into the bladder lumen of immune deficient mice. Protocols are also provided on the use of these models for the preclinical evaluation of new chemical entities, with mTOR inhibitors shown as an example.

Original languageEnglish (US)
Pages (from-to)14.14.1-14.14.18
JournalCurrent Protocols in Pharmacology
Issue numberSUPPL. 49
DOIs
StatePublished - Jun 2010

Funding

Keywords

  • GEM mouse models
  • bladder cancer
  • mTOR inhibition
  • orthotopic models
  • preclinical studies

ASJC Scopus subject areas

  • Pharmacology

Fingerprint

Dive into the research topics of 'Mouse models of human bladder cancer as a tool for drug discovery'. Together they form a unique fingerprint.

Cite this